Information Provided By:
Fly News Breaks for June 30, 2015
JUNO, CELG
Jun 30, 2015 | 08:08 EDT
After Celgene (CELG) announced that it would collaborate with Juno Therapeutics (JUNO) for access to CAR- T therapies, JMP Securities says the deal will help Celgene maintain its dominant position in current and future oncology indications. The firm reiterates a $133 price target and Outperform rating on Celgene.
News For CELG;JUNO From the Last 2 Days
There are no results for your query CELG;JUNO